1-20 of 36
Joel M. Reid
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT114: Pharmacokinetic analysis of navitoclax in combination with sorafenib in patients with relapsed or refractory solid organ tumors

Emily J. Koubek, Brian A. Costello, Jun Yin, Renee M. McGovern, Sarah A. Buhrow, Renee A. Schoon, Carrie A. Strand, Yixing Jiang, Mitesh J. Borad, Naoko Takebe, Scott H. Kaufmann, Alex A. Adjei, Joel M. Reid
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT114.
DOI: https://doi.org/10.1158/1538-7445.AM2020-CT114
Published: 15 August 2020
View article
Journal Articles

Abstract 3078: Effects of upamostat and opaganib on cholangiocarcinoma patient derived xenografts

Faizal Z. Asumda, Mohamed A. Hassan, Yo Han Kim, Nellie A. Campbell, Xin Luo, Daniel R. O'Brien, Sarah A. Buhrow, Joel M. Reid, Michael J. Moore, Vered Katz Ben-Yair, Reza Fathi, Mark L. Levitt, Fabrice Lucien-Matteoni, Jennifer L. Leiting, Mark J. Truty, Lewis R. Roberts
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 3078.
DOI: https://doi.org/10.1158/1538-7445.AM2020-3078
Published: 15 August 2020
View article
Journal Articles

Abstract PD7-06: A randomized phase II trial of tamoxifen versus Z-endoxifen HCL in postmenopausal women with metastatic estrogen receptor positive, HER2 negative breast cancer

Matthew P. Goetz, Vera J Suman, Joel M Reid, Mary Kuffel, Sarah A Buhrow, Renee M McGovern, John Black, Travis Dockter, William F Symmans, Minetta C Liu, John R Hawse, James Doroshow, Anna M Storniolo, Jerry M Collins, Howard Streicher, Matthew M Ames, James N Ingle, Ann Partridge, Lisa Carey
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD7-06.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-PD7-06
Published: 15 February 2020
View article
Journal Articles

Correction: Antibody-Targeted Chemotherapy for the Treatment of Melanoma

Wendy K. Nevala, Sarah A. Buhrow, Daniel J. Knauer, Joel M. Reid, Elena A. Atanasova, Svetomir N. Markovic
Journal: Cancer Research
Cancer Res (2019) 79 (17): 4551.
DOI: https://doi.org/10.1158/0008-5472.CAN-19-1930
Published: 03 September 2019
View article
PDF
Journal Articles

Abstract 3870: The addition of CB-839 to temozolomide significantly reduces glioma aspartate and glutamate in an IDH mutated patient derived glioma xenograft model

Sani Haider Kizilbash, Danielle M. Burgenske, Samuel McBrayer, Sandhya Devarajan, Shiv K. Gupta, Taro Hitosugi, Lihong He, Mark A. Schroeder, Brett L. Carlson, Marina Gelman, Charles A. Kunos, Joel M. Reid, Alex A. Adjei, Jann N. Sarkaria
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3870.
DOI: https://doi.org/10.1158/1538-7445.AM2019-3870
Published: 01 July 2019
View article
Journal Articles

Abstract CT054: A dose escalation and toxicity study using pre-determined target concentration of Ramucirumab, a novel anti-angiogenic agent in children with recurrent / refractory solid tumors: A report from the children's oncology group phase I/ pilot consortium (ADVL1416)

Kamnesh Pradhan, Stacey L. Berg, Xiaowei Liu, Charles G. Minard, James Croop, Joel M. Reid, Elizabeth Fox, Brenda J. Weigel
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT054.
DOI: https://doi.org/10.1158/1538-7445.AM2018-CT054
Published: 01 July 2018
View article
Journal Articles

Abstract CT144: Pediatric phase I trial of the WEE1 inhibitor AZD1775 and irinotecan in patients with refractory solid and CNS malignancies; A Children’s Oncology Group Study (ADVL1312)

Kristina A. Cole, Joel M. Reid, Xiaowei Liu, Charles G. Minard, John M. Maris, Elizabeth Fox, Brenda J. Weigel
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): CT144.
DOI: https://doi.org/10.1158/1538-7445.AM2017-CT144
Published: 01 July 2017
View article
Journal Articles

Antibody-Targeted Chemotherapy for the Treatment of Melanoma

Wendy K. Nevala, Sarah A. Buhrow, Daniel J. Knauer, Joel M. Reid, Elena A. Atanasova, Svetomir N. Markovic
Journal: Cancer Research
Cancer Res (2016) 76 (13): 3954–3964.
DOI: https://doi.org/10.1158/0008-5472.CAN-15-3131
Published: 30 June 2016
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 4631: Pharmacokinetics and in vivo metabolism of Z-endoxifen: Results from two phase I studies in women with ER+ breast cancer, gynecologic malignancies and desmoids

Joel M. Reid, Matthew P. Goetz, Shivaani Kumar, Renee M. McGovern, Sarah A. Buhrow, Stephanie L. Safgren, Vera J. Suman, Travis J. Docktor, Charles Erlichman, Howard Streicher, James H. Doroshow, Jerry Collins, Matthew M. Ames
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4631.
DOI: https://doi.org/10.1158/1538-7445.AM2014-4631
Published: 01 October 2014
View article
Journal Articles

Abstract 4557: LC/MS/MS assay and mouse pharmacokinetics of the phenylurea thiocarbamate NSC 161128.

Chad A. Walden, Joel M. Reid, Renee M. McGovern, Joseh M. Covey, Matthew M. Ames
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4557.
DOI: https://doi.org/10.1158/1538-7445.AM2013-4557
Published: 15 April 2013
View article
Journal Articles

Abstract 2462: Pharmacokinetics and in vivo metabolism of the naphthofuran NSC373981 in male nu/nu mice.

Joel M. Reid, Sarah A. Buhrow, Renee M. McGovern, Joseph M. Covey, Matthew M. Ames
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2462.
DOI: https://doi.org/10.1158/1538-7445.AM2013-2462
Published: 15 April 2013
View article
Journal Articles

Abstract 2273: Metformin promotes tumorigenesis in animal models of cancer prevention.

Clinton J. Grubbs, Margie L. Clapper, Joel M. Reid, Vernon E. Steele, Ronald A. Lubet
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2273.
DOI: https://doi.org/10.1158/1538-7445.AM2013-2273
Published: 15 April 2013
View article
Journal Articles

Abstract 3781: Pharmacokinetics of endoxifen and tamoxifen in female mice: Implications for comparative in vivo activity studies

Stephanie L. Safgren, Sarah A. Buhrow, Chad Walden, Mary J. Kuffel, Kathryn E. Reinicke, Joel M. Reid, Matthew P. Goetz, Matthew M. Ames
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3781.
DOI: https://doi.org/10.1158/1538-7445.AM2012-3781
Published: 15 April 2012
View article
Journal Articles

Abstract 3769: Metabolic activation of batracylin and N-acetylbatracylin to reactive metabolites that bind protein and DNA: Possible role in toxicity

Sarah A. Buhrow, Mary Kuffel, Chad Walden, Joel M. Reid, Joseph Covey, Matthew M. Ames
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3769.
DOI: https://doi.org/10.1158/1538-7445.AM2012-3769
Published: 15 April 2012
View article
Journal Articles

Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas

Shivaani Kummar, Alice Chen, Jiuping Ji, Yiping Zhang, Joel M. Reid, Matthew Ames, Lee Jia, Marcie Weil, Giovanna Speranza, Anthony J. Murgo, Robert Kinders, Lihua Wang, Ralph E. Parchment, John Carter, Howard Stotler, Larry Rubinstein, Melinda Hollingshead, Giovanni Melillo, Yves Pommier, William Bonner, Joseph E. Tomaszewski, James H. Doroshow
Journal: Cancer Research
Cancer Res (2011) 71 (17): 5626–5634.
DOI: https://doi.org/10.1158/0008-5472.CAN-11-1227
Published: 30 August 2011
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 2283: Endoxifen exhibits potent in vitro and in vivo antitumor activity in ER+/HER2+ breast cancer and tamoxifen refractory tumors

Kathryn E. Reinicke, Xiaonan Hou, Matthew P. Goetz, Vera J. Suman, Mary J. Kuffel, Paul Haluska, Joel M. Reid, Matthew M. Ames
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2283.
DOI: https://doi.org/10.1158/1538-7445.AM2011-2283
Published: 15 April 2011
View article
Journal Articles

Abstract 1301: Investigation of a potential pharmacokinetic interaction between ABT-888 and topotecan in a phase I trial

Olumide Kayode, Joel M. Reid, Danel V. Satele, Hui Tang, Paul Haluska, Prema P. Peethambaram, Matthew M. Ames, Alice Chen, Scott H. Kaufmann, Donald W. Northfelt, Charles Erlichman, Michael E. Menefee
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1301.
DOI: https://doi.org/10.1158/1538-7445.AM2011-1301
Published: 15 April 2011
View article
Journal Articles

Abstract 1303: Characterization of the metabolite profile for batracylin and N-acetylbatracylin in rat and human models of invitro and in vivo metabolism: Elucidation of pathways that might contribute to batracylin toxicity

Matthew M. Ames, Joel M. Reid, Sarah A. Buhrow, Mary J. Kuffel, Chad A. Walden, Joseph M. Covey, Holger P. Behrsing, Myrtle Davis Millin
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1303.
DOI: https://doi.org/10.1158/1538-7445.AM2011-1303
Published: 15 April 2011
View article
Journal Articles

Abstract 2607: Endoxifen pharmacokinetics and bioavailability of in female rats and dogs

Joel M. Reid, Sarah A. Buhrow, Stephanie L. Safgren, Lee Jia, Karen Schweikart, Patricia E. Noker, Myrtle Davis, Jerry M. Collins, Matthew P. Goetz, Matthew M. Ames
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2607.
DOI: https://doi.org/10.1158/1538-7445.AM10-2607
Published: 15 April 2010
View article
Journal Articles

Abstract 2662: Pharmacokinetics, metabolism and tissue distribution of the nitric oxide-donating prodrug JS-K following administration in liposomes

Sarah A. Buhrow, Joel M. Reid, Chad A. Walden, Lee Jia, Myrtle Davis, Larry K. Keefer, Heba Barazi, Matthew M. Ames
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2662.
DOI: https://doi.org/10.1158/1538-7445.AM10-2662
Published: 15 April 2010
View article